THE ASSOCIATION BETWEEN TUMOR INFILTRATING LYMPHOCYTES (TILS) LEVELS AND METASTATIC STATUS IN PATIENTS WITH HEAD AND NECK CANCER
DOI:
https://doi.org/10.21460/bikdw.v10i2.1250Keywords:
head and neck cancer, metastasis, predictor, tumor-infiltrating lymphocytesAbstract
Background:
Head and neck cancer (HNC) is a major public health issue, ranking as the seventh most prevalent cancer worldwide. The challenge is the early detection of the disease. Despite progress in imaging techniques, detecting early metastases continues to be problematic. Tumor infiltrating lymphocytes (TILs) have become recognized as key players within the tumor microenvironment, impacting tumor growth and the spread of cancer in multiple types. Their significance as a biomarker has been widely investigated.
Objectives:
This study aimed to investigate the role of TILs level as a predictor of metastasis head and neck cancer.
Method:
This was an observational analytic cross-sectional study of patients at Universitas Gadjah Mada Academic Hospitals and Dr. Sardjito General Hospital, Yogyakarta. The study was performed from Jun 2024 until December 2024 on patients who had been diagnosed head and neck cancer based on histopathologic examination. TILs levels differences between metastatic and non-metastatic head and neck carcinoma cases were assessed using the Chi-square test. Odds ratios (OR) were calculated, and multivariate analysis was conducted. The cut-off point for TILs levels was established through receiver operating characteristic (ROC) curve analysis.
Result:
Seventy-five head and neck cancer patients were involved in this study. The patients were divided into metastatic and non-metastatic groups. The study subjects consisted of 32 patients without metastasis and 43 patients with metastasis. Based on receiver operating characteristic curve, the cut of point 12,5 % with a sensitivity of 62.8% (0.628) and a specificity of 87.5% (0.875). There was a significant difference in TILs levels between the metastatic and non-metastatic groups based on a cut-off value of 12.5 (p = 0.001; OR: 11.8; 95% CI: 3.5–39.8).
Conclusion:
There was a significant difference of TILs levels between metastatic and non-metastatic head and neck carcinoma. The TILs more than 12,5 % can be considered as predictor of decreased metastasis risk in head and neck cancer.
Keywords:
head and neck cancer, metastasis, predictor, tumor-infiltrating lymphocytes
References
References :
1. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the Epidemiology of Head and Neck Cancer: Definitions, Trends and Risk Factors. BDJ. 2022;233(9):780-6.
2. Mohsin SF. Vaccine a Promising Immunotherapy Option for Head and Neck Cancer Patients. Pakistan Journal of Medical Sciences. 2024;40(7).
3. Oualla K, Castelo Branco L, Nouiyakh L, Amaadour L, Benbrahim Z, Arifi S, et al. Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker. Cancer Control. 2021;28:10732748211004878.
4. Huang C, Liu J, Liu H. Identification of the immune cell infiltration landscape in head and neck squamous cell carcinoma (HNSC) for the exploration of immunotherapy and prognosis. Genetics Research. 2022;2022:e2.
5. Wu Q, Shao T, Huang G, Zheng Z, Jiang Y, Zeng W, et al. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma. Biomolecules. 2022;12(10):1458.
6. Behanova E, Pedan H, Hanzel P, Hajtman A, Calkovský V. Distribution of Metastases in Ent Area – Comparison of Theory and Practice. Acta Medica Martiniana. 2021;21(2):54-60.
7. Tamari H, Kitadai Y, Takigawa H, Yuge R, Urabe Y, Shimamoto F, et al. Investigating the Role of Tumor-Infiltrating Lymphocytes as Predictors of Lymph Node Metastasis in Deep Submucosal Invasive Colorectal Cancer: A Retrospective Cross-Sectional Study. Cancers. 2023;15(21):5238.
8. Virgilio AD, Veneroni MV, Costantino A, Festa BM, Fiamengo B, Sebastiani D, et al. Tumor-Infiltrating Lymphocytes and Tumor-Associated Macrophages as Potential Predictors of Lymph Node Metastases in Major Salivary Gland Cancers. Frontiers in Medicine. 2023;10.
9. C?runtu A, Moraru L, Surcel M, Munteanu A, T?nase C, Constantin C, et al. Assessment of Immune Cell Populations in Tumor Tissue and Peripheral Blood Samples From Head and Neck Squamous Cell Carcinoma Patients. Analytical Cellular Pathology. 2021;2021:1-7.
10. Intarawichian P, Sangpaibool S, Prajumwongs P, Sa-Ngiamwibool P, Sangkhamanon S, Kunprom W, et al. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Predicting Outcome of Distal Cholangiocarcinoma in Thailand. Frontiers in Oncology. 2022;12.
11. Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14-7.
12. Shen Z, Wang L, Dong Y. The Expression Profile and Clinical Application Value of Hsa_circ_0016148 in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Laboratory Analysis. 2021;35(11).
13. Almangush A, Jouhi L, Atula T, Haglund C, Mäkitie A, Hagström J, et al. Tumour-Infiltrating Lymphocytes in Oropharyngeal Cancer: A Validation Study According to the Criteria of the International Immuno-Oncology Biomarker Working Group. British Journal of Cancer. 2022;126(11):1589-94.
14. C?runtu A, Moraru L, Lupu M, Vasilescu F, Dumitrescu M, Cioplea M, et al. Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma. Cancers. 2021;13(9):2268.
15. Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Katsumata N. Prognostic Role of Tumor?Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma. The Laryngoscope. 2021;131(11):2512-8.
16. Suwalska A, Zientek L, Pola?ska J, Marczyk M. Quantifying Spatial Heterogeneity of Tumor-Infiltrating Lymphocytes to Predict Survival of Individual Cancer Patients. Journal of Personalized Medicine. 2022;12(7):1113.
17. Fanale D, Dimino A, Pedone E, Brando C, Corsini LR, Filorizzo C, et al. Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer. Cancers. 2022;14(18):4344.
18. Shao B, Zheng Y, Sun B, Zhang X. Molecular Evolutionary Landscape of the Immune Microenvironment of Head and Neck Cancer. Biomolecules. 2023;13(7):1120.
19. Mito I, Takahashi H, Kawabata?Iwakawa R, Ida S, Tada H, Chikamatsu K. Comprehensive Analysis of Immune Cell Enrichment in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma. Scientific Reports. 2021;11(1).
20. Yu J, Sun X, Zhao Y, Chang Z, Zhou B. Development and Validation of an Individualized Immune Prognostic Signature in HNSCC. 2022.
21. Polesel J, Menegaldo A, Tirelli G, Giacomarra V, Guerrieri R, Baboci L, et al. Prognostic Significance of PD-L1 Expression in Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis. Frontiers in Oncology. 2021;11.
22. Nagy Á, Munkácsy G, Gy?rffy B. Pancancer Survival Analysis of Cancer Hallmark Genes. Scientific Reports. 2021;11(1).
23. Wondergem NE, Nauta I, Muijlwijk T, Leemans CR, Ven Rvd. The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: On Subsets and Subsites. Current Oncology Reports. 2020;22(8).
24. Wang J, Tian S, Sun J, Zhang J, Lin L, Hu C. The Presence of Tumour-Infiltrating Lymphocytes (TILs) and the Ratios Between Different Subsets Serve as Prognostic Factors in Advanced Hypopharyngeal Squamous Cell Carcinoma. BMC Cancer. 2020;20(1).
25. Agarwal A, Kansal V, Farooqi H, Prasad R, Singh VK. Inhibition of miR-214 Expression by Small Molecules Alleviates Head and Neck Cancer Metastasis by Targeting ALCAM/TFAP2 Signaling. 2023.
26. Yun M, Choi AJ, Woo SR, Noh JK, Sung JY, Lee J, et al. Inhibition of Carbonyl Reductase 1 Enhances Metastasis of Head and Neck Squamous Cell Carcinoma Through ?-Catenin-Mediated Epithelial-Mesenchymal Transition. Journal of Cancer. 2020;11(3):533-41.
Downloads
Published
Issue
Section
Citation Check
License
Copyright (c) 2025 Anton Sony Wibowo, Sulis Ernawati, Herfis Avidati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish in Berkala Ilmiah Kedokteran Duta Wacana agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under CC BY-SA 4.0
